StockWatch
·
Medical Electronics
Quarterly ResultJun 25, 2026, 08:07 AM

Nanox Q1 Revenue $4.3M; Withdraws 2026 Guidance; Going Concern Doubt

AI Summary

Nano-X Imaging Ltd. reported Q1 2026 revenue of $4.3 million, an increase from $2.8 million in Q1 2025, but its GAAP net loss widened to $14.3 million. The company withdrew its 2026 revenue target and will no longer provide annual guidance due to variability in deployment timelines and revenue recognition. Management raised substantial doubt about its ability to continue as a going concern, citing insufficient cash for operations beyond one year. Additionally, a class action lawsuit was filed on June 12, 2026, alleging federal securities law violations.

Key Highlights

  • Q1 2026 revenue increased to $4.3 million from $2.8 million in Q1 2025.
  • GAAP net loss widened to $14.3 million in Q1 2026 from $13.2 million in Q1 2025.
  • Cash and equivalents decreased to $44.2 million as of March 31, 2026, from $60.0 million on Dec 31, 2025.
  • Company withdrew its 2026 revenue target and will no longer provide annual revenue guidance.
  • Management raised substantial doubt about its ability to continue as a going concern.
  • Approximately 40 Nanox.ARC systems are in various stages of deployment.
  • A class action lawsuit was filed on June 12, 2026, alleging federal securities law violations.
  • Evaluating restructuring, sale, or wind-down of South Korea operations.